ArticleBMC surgery2025
A retrospective study of 3D-printed custom titanium prostheses for reconstruction of bone defects after resection of pelvic tumors: technical points and early results.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Current Treatment Options and Emerging Technologies for Pelvic Bone Tumors: From Limb Salvage to Precision Oncology.Current treatment options in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundWith the development of limb salvage technology for pelvic malignant tumor, 3D-printed custom prosthesis has become a main way to reconstruct pelvis after resection of pelvic malignant tumor. the purpose of this study is to explore the technical points of using 3D-printed custom titanium alloy prosthesis to reconstruct bone defect after resection of pelvic tumor, and to analyze the early curative effect, complications and prognosis, in order to provide clinical reference for the resection and reconstruction of pelvic malignant tumor.
methodsWe reviewed 7 patients (4 males, 3 females; mean age 42 years, range 16–54) receiving 3D-printed titanium alloy prostheses for pelvic reconstruction following malignant tumor resection (June 2022-December 2023). Cases included 4 primary bone malignancies (2 chondrosarcomas, 2 osteosarcomas) and 3 secondary malignant tumors (endometrial, rectal, hepatocellular carcinomas). Enneking zones involved I + II/I + II + III/II + III (n = 4) and I + II + IV/I + II + III + IV (n = 3), with resections including wide (n = 3), marginal (n = 3), and intracapsular (n = 1). VAS and KPS assessed pain and physical strength preoperatively and at 1/3/6 months postoperatively. MSTS 93 evaluated limb function pre-/postoperatively. Pelvic stability was assessed via pre- and 6-month postoperative sacroiliac joint space measurements. Complications were documented during follow-up (mean 10.6 months, range 6-18.2), while overall survival, progression-free survival, and prognostic factors were analyzed using Kaplan-Meier/COX methods.
resultsAll 7 patients underwent successful procedures, comprising 5 standard semi-pelvic/iliac prosthesis implantations and 2 screw-connected semi-pelvic reconstructions. Significant improvements were observed in both pain and functional outcomes. The median preoperative VAS score was 7.0 (IQR 6.0-8.5), which decreased to 4.0 (3.5-5.0) at 1 month, 3.0 (2.0-4.5) at 3 months, and 2.5 (2.0-3.5) at 6 months (χ² = 9.46, P = 0.024), with all pairwise comparisons remaining significant after Bonferroni correction (P < 0.001). Simultaneously, median KPS scores improved from 60.0 (40.0–60.0) preoperatively to 60.0 (50.0–70.0) at 1 month, 70.0 (60.0–80.0) at 3 months, and 80.0 (70.0–80.0) at 6 months (χ² = 13.36, P = 0.004), with all inter-timepoint comparisons also statistically significant (P < 0.001). The mean MSTS 93 score was 11.00 ± 4.20 preoperatively and significantly improved to 23.86 ± 4.06 at 3 months postoperatively (P < 0.001). A significant difference in the contralateral sacroiliac joint space was observed between preoperative and 6-month postoperative measurements in patients with Zone IV involvement (IV group) (P = 0.048). Complications included heterotopic ossification (4/7, 57.1%), pubic screw fracture (1/7, 14.3%), femoral neck dislocation (1/7, 14.3%), delayed wound healing (1/7, 14.3%), local recurrence (2/7, 42.8%), and distal metastasis (2/7, 42.8%). No deep infection, periprosthetic osteolysis, or implant loosening occurred. With a mean follow-up of 10.6 months (range: 6–18.2 months), one patient died due to tumor recurrence and metastasis. Kaplan–Meier analysis and Cox multivariate regression showed that gender, tumor type, extent of resection, and Zone IV involvement were not significant variables affecting progression-free survival.
conclusion3D-printed custom titanium alloy prostheses exhibit favourable early efficacy, safety, and prognostic outcomes in the reconstruction of pelvic defects following tumor resection. Nevertheless, observed alterations in the contralateral unaffected sacroiliac joint space following Zone IV reconstruction have led to a hypothesis regarding potential instability risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.